Specialty / Expertise

Genitorurinary cancers

Research Interests

PET-imaging

Current Research Projects

Research Staff

Training

Dr. Yu received his MD from the University of Washington, Seattle, WA. He completed his Internal Medicine Residency at the Brigham and Women's Hospital, Boston, MA. He was a Post-Doctoral Fellow in Hematology-Oncology at the Dana Farber Cancer Institute, Boston, MA.

Selected Publications:

Yu EY, Mankoff DA. Positron emission tomography imaging as a cancer biomarker. Expert Rev Mol Diagn 2007 7(5):659-672.

Yu EY, Hahn WC. Genetic alterations in prostate cancer. Clin Prostate Cancer 2005 3:220-229.

Yu EY, Hahn WC. The origin of cancer. In: Farid NR, editor. Molecular basis of thyroid cancer. Norwell: Kluwer Academic Publishers, 2004, Chapter 1:1-22.

Yu EY, Hahn WC, George DJ, Kantoff PW. Opportunities for targeted molecular therapy for prostate cancer. In: Klein EA, editor. Management of prostate cancer. Totowa: Humana Press, 2004, Chapter 35:631-652.

Yu EY, Oh WK. Neoadjuvant therapy for high-risk localized prostate cancer. Curr Oncol Rep 2003 5:250-257.

Masutomi K, Yu EY, Khurts S, Ben-Porath i, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC. Telomerase maintains telomere structure in normal human cells. Cell 2003 114:241-253.